GE SIGNA Premier Elite (China Only), Nuclear Magnetic Resonance Imaging System

Recall Insight

This FDA Devices action (record #Z-2314-2025) was formally reported on August 20, 2025, with the manufacturer initiating the action on June 20, 2025. It is classified under Moderate severity (Class II), with a current status of Ongoing. GE Medical Systems, LLC is listed as the recalling firm, operating out of Waukesha, WI. Federal records indicate 0 units are affected.

The documented reason for this recall is: GE HealthCare has become aware that for certain MR systems (SIGNA Artist, SIGNA Voyager, Discovery MR450 1.5T, Optima MR450w 1.5T, SIGNA Architect, SIGNA Premier, SIGNA UHP, Discovery MR750 3.0T, Discovery MR750w 3.0T, … Distribution data in the federal record shows the product reached: Worldwide distribution.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

To put this record in context, PlainRecalls indexes 83,949 recalls across the FDA, CPSC, NHTSA and USDA FSIS going back to 1995. Within the same product category, the database holds 6 closely related recalls, of which 6 were also issued by FDA Devices. That clustering is a signal — repeated actions in a narrow category often indicate a systemic quality-control issue, a supplier-wide contamination, or a design defect that has propagated across product lines. This recall is roughly 1 year old; older recalls can remain relevant because many units enter resale, rental, and secondary-market channels where the original warning never reaches the end user. Always cross-check the recall number against the official agency page before relying on any summary.